PT668763E - Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento - Google Patents
Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimentoInfo
- Publication number
- PT668763E PT668763E PT94903295T PT94903295T PT668763E PT 668763 E PT668763 E PT 668763E PT 94903295 T PT94903295 T PT 94903295T PT 94903295 T PT94903295 T PT 94903295T PT 668763 E PT668763 E PT 668763E
- Authority
- PT
- Portugal
- Prior art keywords
- fenserin
- medicines
- knowledge
- preparation
- treat diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/980,399 US5409948A (en) | 1992-11-23 | 1992-11-23 | Method for treating cognitive disorders with phenserine |
Publications (1)
Publication Number | Publication Date |
---|---|
PT668763E true PT668763E (pt) | 2002-08-30 |
Family
ID=25527533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94903295T PT668763E (pt) | 1992-11-23 | 1993-11-23 | Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento |
Country Status (11)
Country | Link |
---|---|
US (1) | US5409948A (de) |
EP (1) | EP0668763B1 (de) |
JP (1) | JP3778363B2 (de) |
AT (1) | ATE213411T1 (de) |
AU (1) | AU693428B2 (de) |
CA (1) | CA2149924C (de) |
DE (1) | DE69331605T2 (de) |
DK (1) | DK0668763T3 (de) |
ES (1) | ES2173111T3 (de) |
PT (1) | PT668763E (de) |
WO (1) | WO1994012176A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2264750C (en) * | 1997-07-09 | 2009-06-16 | Nigel H. Greig | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
US20030125609A1 (en) * | 2001-08-03 | 2003-07-03 | Robert Becker | Method for reliable measurement in medical care and patient self monitoring |
US6495700B1 (en) | 2002-01-09 | 2002-12-17 | Axonyx, Inc. | Process for producing phenserine and its analog |
US7612078B2 (en) | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
WO2005042475A2 (en) * | 2003-10-21 | 2005-05-12 | Sention, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
WO2005089746A1 (en) * | 2004-03-19 | 2005-09-29 | Axonyx, Inc. | Dosage titration for treatment of cognitive disorders |
US20070213388A1 (en) * | 2004-03-19 | 2007-09-13 | Bruinsma Gosse B | Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Antagonists Useful in the Treatment of of Cognitive Disorders |
US7488736B2 (en) | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
CA2508585A1 (en) * | 2004-06-01 | 2005-12-01 | Axonyx, Inc. | Transdermal delivery system for treatment of cognitive disorders |
WO2005123068A2 (en) * | 2004-06-08 | 2005-12-29 | Axonyx, Inc. | Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
US20060194723A1 (en) * | 2005-02-28 | 2006-08-31 | Rabinoff Michael D | Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
WO2006138385A2 (en) * | 2005-06-14 | 2006-12-28 | Cancog Technologies Inc.24 | Use of phenserine and analogs to treat behavioral problems and improve trainability |
MX2009008288A (es) * | 2007-02-02 | 2009-12-01 | Colucid Pharmaceuticals Inc | Compuestos que inhiben la colinesterasa. |
RU2327480C1 (ru) | 2007-05-23 | 2008-06-27 | Виктор Иванович Рощин | Активный ингредиент лекарственного средства, лекарственное средство, фармацевтическая композиция и способ лечения больных с дементным синдромом |
WO2009011901A2 (en) * | 2007-07-18 | 2009-01-22 | Colucid Pharmaceuticals, Inc. | Methods for promoting wakefulness |
US8593728B2 (en) * | 2009-02-19 | 2013-11-26 | Toyota Motor Engineering & Manufacturing North America, Inc. | Multilayer photonic structures |
US8114894B2 (en) | 2008-12-03 | 2012-02-14 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
PT2453890T (pt) * | 2009-07-17 | 2020-08-25 | Allergan Inc | Composições compreendendo um inibidor de colinesterase para tratar perturbações cognitivas |
US20120225922A1 (en) * | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
AU2016309815B2 (en) | 2015-08-14 | 2022-04-07 | Annovis Bio, Inc. | Methods of treatment or prevention of acute brain or nerve injuries |
US10864192B2 (en) | 2016-01-15 | 2020-12-15 | Aristea Translational Medicine Corporation | Compositions and methods for inhibiting brain trauma-induced neurodegeneration and related conditions |
US10111860B1 (en) | 2016-01-15 | 2018-10-30 | Aristea Translational Medicine Corporation | Compositions and methods for treating concussion |
CA3083015A1 (en) | 2017-05-24 | 2018-11-28 | Qr Pharma, Inc. | Prevention or treatment of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US479107A (en) * | 1892-07-19 | oesterreich | ||
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
DE3843239C1 (de) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
US4971992A (en) * | 1989-03-27 | 1990-11-20 | Hoechst-Roussel Pharmaceuticals Inc. | Carbonate derivatives of eseroline |
US4996201A (en) * | 1989-08-02 | 1991-02-26 | Warner-Lambert Co. | 4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents |
US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
US5077289A (en) * | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
-
1992
- 1992-11-23 US US07/980,399 patent/US5409948A/en not_active Expired - Lifetime
-
1993
- 1993-11-23 JP JP51335894A patent/JP3778363B2/ja not_active Expired - Fee Related
- 1993-11-23 DK DK94903295T patent/DK0668763T3/da active
- 1993-11-23 ES ES94903295T patent/ES2173111T3/es not_active Expired - Lifetime
- 1993-11-23 AU AU57290/94A patent/AU693428B2/en not_active Ceased
- 1993-11-23 DE DE69331605T patent/DE69331605T2/de not_active Expired - Fee Related
- 1993-11-23 EP EP94903295A patent/EP0668763B1/de not_active Expired - Lifetime
- 1993-11-23 CA CA002149924A patent/CA2149924C/en not_active Expired - Fee Related
- 1993-11-23 PT PT94903295T patent/PT668763E/pt unknown
- 1993-11-23 AT AT94903295T patent/ATE213411T1/de not_active IP Right Cessation
- 1993-11-23 WO PCT/US1993/011423 patent/WO1994012176A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69331605T2 (de) | 2002-10-31 |
DK0668763T3 (da) | 2002-06-03 |
AU5729094A (en) | 1994-06-22 |
ATE213411T1 (de) | 2002-03-15 |
AU693428B2 (en) | 1998-07-02 |
WO1994012176A1 (en) | 1994-06-09 |
JP3778363B2 (ja) | 2006-05-24 |
DE69331605D1 (de) | 2002-03-28 |
ES2173111T3 (es) | 2002-10-16 |
CA2149924A1 (en) | 1994-06-09 |
JPH08505130A (ja) | 1996-06-04 |
US5409948A (en) | 1995-04-25 |
CA2149924C (en) | 2006-01-31 |
EP0668763B1 (de) | 2002-02-20 |
EP0668763A1 (de) | 1995-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT668763E (pt) | Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
EP0348353A3 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
HU9602583D0 (en) | Gel for treatment of skin diseases and for disinfection of the skin | |
ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
PL338982A1 (en) | Drug for improving duration of muscle action or for treating muscular disorders or diseases | |
NO944018L (no) | Behandling av makulær degenerasjon | |
DE69426334D1 (de) | Parenterales Busulfan zur Behandlung von malignen Krankheiten | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
BR9500436A (pt) | Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico | |
DE69307702D1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
NZ268039A (en) | Use of efaroxan in treating parkinson's disease | |
HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
NO984196L (no) | FremgangsmÕte for behandling av stoffmisbruk | |
DE69800906D1 (de) | Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie | |
KR920009403A (ko) | 수면장해 치료용 이미다조벤조디아제핀 | |
ZA936136B (en) | Treatment of skin diseases | |
EA200200559A1 (ru) | Способ лечения и профилактики нейродегенеративных состояний | |
ZA897549B (en) | Medicament for the treatment of diseases caused by retroviruses | |
RU95112756A (ru) | Способ лечения умственной отсталости при болезни дауна | |
MX9704887A (es) | Composiciones farmaceuticas para el tratamiento de trastornos depresivos. | |
BG98001U (en) | Medicament for the treatment of hyperkeratotic conditions of the skin | |
GR862563B (en) | Medicament and cosmetic for the treatment of psoriasis or other skin diseases and haemorrhoids | |
UA7951A (uk) | Спосіб сочетаної вакуум-лазерної терапії | |
IT1277609B1 (it) | Apparecchiatura per l'inattivazione virale di hiv in emoderivati e per supporto a trattamenti terapeutici di affezioni virali da hiv |